Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2

38Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Because stromal cells can regulate the growth and metastasis of tumor cells, a compound that modulates the interaction between the stromal cells and the tumor cells can control the tumor progression. In the course of our screening for such a compound, we have isolated a new compound, intervenolin, from the culture broth of Nocardia sp. ML96-86F2. Intervenolin inhibits the growth of human gastric and colorectal cancer cell lines in the coculture with the respective organ-derived stromal cells more strongly than that of the cancer cells cultured alone. Intervenolin shows antitumor effect against a xenograft model of human colorectal cancer cells in vivo. Furthermore, intervenolin exerts selective anti-Helicobacter pylori effect. © 2013 Japan Antibiotics Research Association All rights reserved.

Cite

CITATION STYLE

APA

Kawada, M., Inoue, H., Ohba, S. I., Hatano, M., Amemiya, M., Hayashi, C., … Nomoto, A. (2013). Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2. Journal of Antibiotics, 66(9), 543–548. https://doi.org/10.1038/ja.2013.42

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free